Hakutulokset - Jamie E. Chaft

Tarkenna hakua
  1. 1
    Immunotherapy in surgically resectable non-small cell lung cancer

    Immunotherapy in surgically resectable non-small cell lung cancer Tekijä Dwight H. Owen, Jamie E. Chaft

    Julkaistu 2018
    Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  2. 2
    Early-stage ALK-positive lung cancer: a narrative review

    Early-stage ALK-positive lung cancer: a narrative review Tekijä Monica F. Chen, Jamie E. Chaft

    Julkaistu 2023
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  3. 3
    ALK-Rearranged Lung Cancer: Adenosquamous Lung Cancer Masquerading as Pure Squamous Carcinoma

    ALK-Rearranged Lung Cancer: Adenosquamous Lung Cancer Masquerading as Pure Squamous Carcinoma Tekijä Jamie E. Chaft, Natasha Rekhtman, Marc Ladanyi, Gregory J. Riely

    Julkaistu 2012
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  4. 4
    Immune checkpoint inhibitors: a narrative review of considerations for the anaesthesiologist

    Immune checkpoint inhibitors: a narrative review of considerations for the anaesthesiologist Tekijä Alexandra Lewis, Jamie E. Chaft, Monica Girotra, Gregory W. Fischer

    Julkaistu 2020
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  5. 5
    Preoperative and Postoperative Systemic Therapy for Operable Non–Small-Cell Lung Cancer

    Preoperative and Postoperative Systemic Therapy for Operable Non–Small-Cell Lung Cancer Tekijä Jamie E. Chaft, Yu Shyr, Boris Sepesi, Patrick M. Forde

    Julkaistu 2022
    Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  6. 6
    Chemotherapy remains an essential element of personalized care for persons with lung cancers

    Chemotherapy remains an essential element of personalized care for persons with lung cancers Tekijä Matthew D. Hellmann, Bingyu Li, Jamie E. Chaft, Mark G. Kris

    Julkaistu 2016
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  7. 7
    Outcomes of chemotherapies and HER2 directed therapies in advanced HER2-mutant lung cancers

    Outcomes of chemotherapies and HER2 directed therapies in advanced HER2-mutant lung cancers Tekijä Juliana Eng, Meier Hsu, Jamie E. Chaft, Mark G. Kris, Maria E. Arcila, Bob T. Li

    Julkaistu 2016
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  8. 8
    Initial Experience With Lung Cancer Resection After Treatment With T-Cell Checkpoint Inhibitors

    Initial Experience With Lung Cancer Resection After Treatment With T-Cell Checkpoint Inhibitors Tekijä Jamie E. Chaft, Matthew D. Hellmann, Moises J. Velez, William D. Travis, Valerie W. Rusch

    Julkaistu 2017
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  9. 9
    Evolution of systemic therapy for stages I–III non-metastatic non-small-cell lung cancer

    Evolution of systemic therapy for stages I–III non-metastatic non-small-cell lung cancer Tekijä Jamie E. Chaft, Andreas Rimner, Walter Weder, Christopher G. Azzoli, Mark G. Kris, Tina Cascone

    Julkaistu 2021
    Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  10. 10
    Disease Flare after Tyrosine Kinase Inhibitor Discontinuation in Patients with <i>EGFR</i>-Mutant Lung Cancer and Acquired Resistance to Erlotinib or Gefitinib: Implications for Clinical Trial Design

    Disease Flare after Tyrosine Kinase Inhibitor Discontinuation in Patients with <i>EGFR</i>-Mutant Lung Cancer and Acquired Resistance to Erlotinib or Gefitinib: Implications for Cl... Tekijä Jamie E. Chaft, Geoffrey R. Oxnard, Camelia S. Sima, Mark G. Kris, Vincent A. Miller, Gregory J. Riely

    Julkaistu 2011
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  11. 11
    Clinical Outcomes with Perioperative Chemotherapy in Sarcomatoid Carcinomas of the Lung

    Clinical Outcomes with Perioperative Chemotherapy in Sarcomatoid Carcinomas of the Lung Tekijä Jamie E. Chaft, Camelia S. Sima, Michelle S. Ginsberg, James Huang, Mark G. Kris, William D. Travis, Christopher G. Azzoli

    Julkaistu 2012
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  12. 12
    Association of <i>KRAS</i> and <i>EGFR</i> mutations with survival in patients with advanced lung adenocarcinomas

    Association of <i>KRAS</i> and <i>EGFR</i> mutations with survival in patients with advanced lung adenocarcinomas Tekijä Melissa L. Johnson, Camelia S. Sima, Jamie E. Chaft, Paul K. Paik, William Pao, Mark G. Kris, Marc Ladanyi, Gregory J. Riely

    Julkaistu 2012
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  13. 13
    <i>EGFR</i> Exon 20 Insertion Mutations in Lung Adenocarcinomas: Prevalence, Molecular Heterogeneity, and Clinicopathologic Characteristics

    <i>EGFR</i> Exon 20 Insertion Mutations in Lung Adenocarcinomas: Prevalence, Molecular Heterogeneity, and Clinicopathologic Characteristics Tekijä Maria E. Arcila, Khédoudja Nafa, Jamie E. Chaft, Natasha Rekhtman, Christopher Lau, Boris Reva, Maureen F. Zakowski, Mark G. Kris, Marc Ladanyi

    Julkaistu 2013
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  14. 14
    Prognostic impact of TTF-1 expression in patients with stage IV lung adenocarcinomas

    Prognostic impact of TTF-1 expression in patients with stage IV lung adenocarcinomas Tekijä Juliana Schilsky, Ai Ni, Linda S. Ahn, Sutirtha Datta, William D. Travis, Mark G. Kris, Jamie E. Chaft, Natasha Rekhtman, Matthew D. Hellmann

    Julkaistu 2017
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  15. 15
    Neoadjuvant Osimertinib With/Without Chemotherapy Versus Chemotherapy Alone for <i>EGFR</i> -Mutated Resectable Non-Small-Cell Lung Cancer: NeoADAURA

    Neoadjuvant Osimertinib With/Without Chemotherapy Versus Chemotherapy Alone for <i>EGFR</i> -Mutated Resectable Non-Small-Cell Lung Cancer: NeoADAURA Tekijä Masahiro Tsuboi, Walter Weder, Carles Escriu, Collin M. Blakely, Jianxing He, Sanja Đačić, Yasushi Yatabe, Lingmin Zeng, Andrew Walding, Jamie E. Chaft

    Julkaistu 2021
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  16. 16
    HER2 Amplification and HER2 Mutation Are Distinct Molecular Targets in Lung Cancers

    HER2 Amplification and HER2 Mutation Are Distinct Molecular Targets in Lung Cancers Tekijä Bob T. Li, Dara S. Ross, Dara L. Aisner, Jamie E. Chaft, Meier Hsu, Severine Kako, Mark G. Kris, Marileila Varella‐Garcia, Maria E. Arcila

    Julkaistu 2015
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  17. 17
    Prevalence, Clinicopathologic Associations, and Molecular Spectrum of <i>ERBB2</i> (<i>HER2</i>) Tyrosine Kinase Mutations in Lung Adenocarcinomas

    Prevalence, Clinicopathologic Associations, and Molecular Spectrum of <i>ERBB2</i> (<i>HER2</i>) Tyrosine Kinase Mutations in Lung Adenocarcinomas Tekijä Maria E. Arcila, Jamie E. Chaft, Khédoudja Nafa, Sinchita Roy‐Chowdhuri, Christopher Lau, Michael Zaidinski, Paul K. Paik, Maureen F. Zakowski, Mark G. Kris, Marc Ladanyi

    Julkaistu 2012
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  18. 18
    Impact of Concurrent PIK3CA Mutations on Response to EGFR Tyrosine Kinase Inhibition in EGFR-Mutant Lung Cancers and on Prognosis in Oncogene-Driven Lung Adenocarcinomas

    Impact of Concurrent PIK3CA Mutations on Response to EGFR Tyrosine Kinase Inhibition in EGFR-Mutant Lung Cancers and on Prognosis in Oncogene-Driven Lung Adenocarcinomas Tekijä Juliana Eng, Kaitlin M. Woo, Camelia S. Sima, Andrew J. Plodkowski, Matthew D. Hellmann, Jamie E. Chaft, Mark G. Kris, Maria E. Arcila, Marc Ladanyi, Alexander Drilon

    Julkaistu 2015
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  19. 19
    Pathological response in resectable non–small cell lung cancer: a systematic literature review and meta-analysis

    Pathological response in resectable non–small cell lung cancer: a systematic literature review and meta-analysis Tekijä Nathalie Waser, Melanie Quintana, Bernd Schweikert, Jamie E. Chaft, Lindsay R. Berry, Ahmed Adam, Lien Vo, John R. Penrod, Joseph Fiore, Donald A. Berry, Sarah Goring

    Julkaistu 2024
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  20. 20
    Serpins Promote Cancer Cell Survival and Vascular Co-Option in Brain Metastasis

    Serpins Promote Cancer Cell Survival and Vascular Co-Option in Brain Metastasis Tekijä Manuel Valiente, Anna C. Obenauf, Xin Jin, Qing Chen, Xiang H.-F. Zhang, Derek J. Lee, Jamie E. Chaft, Mark G. Kris, Jason T. Huse, Edi Brogi, Joan Massagué

    Julkaistu 2014
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:

Työkalut: